Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATRICIA
2014-005006-38Phase 2Recruiting
- Sponsor
- SOLTI
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of palbociclib, trastuzumab and letrozole in breast cancer (2 arms), sponsored by SOLTI. Primary endpoint: Progression-free survival at 6 months. Started Jan 2015; status: recruiting.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2014-005006-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005006-38.